Anti-Aurora B 抗体 [EP1009Y] (ab45145)

ab45145 は 9 報の論文で使用されています。

• Henssen AG  et al. Targeting tachykinin receptors in neuroblastoma. Oncotarget 8:430-443 (2017). WB ; Human . PubMed: 27888795
• Zhang X  et al. Mps1 kinase regulates tumor cell viability via its novel role in mitochondria. Cell Death Dis 7:e2292 (2016). WB, ICC/IF . PubMed: 27383047
• Chuang MJ  et al. The HDAC inhibitor LBH589 induces ERK-dependent prometaphase arrest in prostate cancer via HDAC6 inactivation and down-regulation. PLoS One 8:e73401 (2013). WB ; Human . PubMed: 24023871
• Failes TW  et al. Evolution of resistance to Aurora kinase B inhibitors in leukaemia cells. PLoS One 7:e30734 (2012). WB, ICC/IF ; Human . PubMed: 22359551
• Fraedrich K  et al. Targeting aurora kinases with danusertib (PHA-739358) inhibits growth of liver metastases from gastroenteropancreatic neuroendocrine tumors in an orthotopic xenograft model. Clin Cancer Res 18:4621-32 (2012). Human . PubMed: 22753592
• Fichter CD  et al. Occurrence of multipolar mitoses and association with Aurora-A/-B kinases and p53 mutations in aneuploid esophageal carcinoma cells. BMC Cell Biol 12:13 (2011). WB . PubMed: 21470402
• Shah OJ  et al. Bcl-XL represents a druggable molecular vulnerability during aurora B inhibitor-mediated polyploidization. Proc Natl Acad Sci U S A 107:12634-9 (2010). PubMed: 20616035
• Ikezoe T  et al. Analysis of Aurora B kinase in non-Hodgkin lymphoma. Lab Invest 89:1364-73 (2009). PubMed: 19823168
• Fiskus W  et al. Cotreatment with vorinostat enhances activity of MK-0457 (VX-680) against acute and chronic myelogenous leukemia cells. Clin Cancer Res 14:6106-15 (2008). PubMed: 18829489